These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15849373)

  • 1. L-arginine and cardiovascular system.
    Cylwik D; Mogielnicki A; Buczko W
    Pharmacol Rep; 2005; 57(1):14-22. PubMed ID: 15849373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
    Durante W; Johnson FK; Johnson RA
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
    J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of L-arginine as physiological precursor of nitric oxide.
    Hăulică I; Coşovanu A; Ungureanu G; Zaharia D; Bălţatu O; Boişteanu D
    Rom J Intern Med; 1994; 32(3):195-201. PubMed ID: 7532511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
    Panza JA; Casino PR; Badar DM; Quyyumi AA
    Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.
    Goumas G; Tentolouris C; Tousoulis D; Stefanadis C; Toutouzas P
    Atherosclerosis; 2001 Feb; 154(2):255-67. PubMed ID: 11166757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology].
    Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG
    Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-arginine and hypertension.
    Gokce N
    J Nutr; 2004 Oct; 134(10 Suppl):2807S-2811S; discussion 2818S-2819S. PubMed ID: 15465790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [L-Arginine and vascular health].
    Ströhle A; von Bibra H; Hahn A
    Med Monatsschr Pharm; 2016 Dec; 39(12):515-20. PubMed ID: 29979511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-arginine in cardiovascular disease: dream or reality?
    Tousoulis D; Antoniades C; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
    Vasc Med; 2002 Aug; 7(3):203-11. PubMed ID: 12553744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the L-arginine-nitric oxide pathway in the changes in cerebrovascular reactivity following hemorrhagic hypotension and retransfusion.
    Szabó C; Csáki C; Benyó Z; Reivich M; Kovách AG
    Circ Shock; 1992 Aug; 37(4):307-16. PubMed ID: 1446389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-arginine: a new opportunity in the management of clinical derangements in dialysis patients.
    Bellinghieri G; Santoro D; Mallamace A; Di Giorgio RM; De Luca G; Savica V
    J Ren Nutr; 2006 Jul; 16(3):245-7. PubMed ID: 16825029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
    Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
    Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial circulatory effect of L-arginine.
    Nakaki T; Kato R
    Jpn J Pharmacol; 1994 Oct; 66(2):167-71. PubMed ID: 7532730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis.
    Schini-Kerth VB
    Transfus Clin Biol; 1999 Dec; 6(6):355-63. PubMed ID: 10666793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of dietary L-arginine supplementation.
    Preli RB; Klein KP; Herrington DM
    Atherosclerosis; 2002 May; 162(1):1-15. PubMed ID: 11947892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits.
    Singer AH; Tsao PS; Wang BY; Bloch DA; Cooke JP
    J Cardiovasc Pharmacol; 1995 May; 25(5):710-6. PubMed ID: 7630149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.